Mayne Pharma Group Ltd (ASX:MYX)
A$ 4.58 -0.05 (-1.08%) Market Cap: 389.64 Mil Enterprise Value: 279.18 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 75/100

Mayne Pharma Group Ltd Annual Shareholders Meeting Transcript

Nov 23, 2020 / 11:00PM GMT
Release Date Price: A$7.1
Roger Campbell Corbett
Mayne Pharma Group Limited - Independent Chairman

I would now like to introduce our Board members, senior executives and company auditors who are all present today online. Joining me in Sydney, fellow directors, Professor Bruce Robinson; and Nancy Dolan.

Nancy Dolan
Mayne Pharma Group Limited - Independent Non-Executive Director

Good morning.

Roger Campbell Corbett
Mayne Pharma Group Limited - Independent Chairman

In Melbourne, we have Ian Scholes; Peter Paltoglou, our CFO; and David Petersen, our company auditor.

In the U.S.A., we have Scott Richards in Raleigh, North Carolina. Also online today, we have our 2 U.S.-based nonexecutive directors, Frank Condella and Pat Blake. And Bruce Mathieson is online from Queensland. Lisa Pendlebury, Vice President, Investor Relations, will moderate the shareholder questions. That have been asked both prior to the meeting and during the meeting as we have our -- and are assisted by or with our Company Secretary, Laura Loftus.

I now

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot